drugset / Trial / NCT06164431
Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to establish bioavailability of 2 treatments with ZSP1273: 200mg tablets and 200mg granules will be given to healthy Participants under fasting conditions. Bioavailability will be evaluated and verified on the basis of pharmacokinetic data.
Timeline
- Start
- 2023-11-23
- Primary completion
- 2023-12-15
- Completion
- 2023-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Onradivir | Small molecule | 200 mg | Oral |
Indications
No indication recorded.